Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human
1. 系统已在2025-04-30 14:54:24对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1080/00498254.2024.2415103
文献链接: https://www.tandfonline.com/doi/full/10.1080/00498254.2024.2415103
其他信息:
出版社: Informa UK Limited
作者: Laurent Salphati; Jodie Pang; Emile G. Plise; Jonathan Cheong; Marie-Gabrielle Braun; Lori S. Friedman; Rebecca Hong Thibodeau; Allan Jaochico; Ryan Johnson; Ning Liu; Michelle Nannini; Deepak Sampath; Kyung Song; Emily J. Hannan; Steven T. Staben